Banook

What Banook does

Banook is a privately held French clinical trial services provider founded in 1999 and headquartered in Nancy, France. The company delivers specialized endpoint and clinical development services to pharmaceutical companies across five integrated service lines: Cardiac Safety, Central Imaging, Respiratory, e-Clinical, and Endpoint Adjudication, supported by project and data management, regulatory, site support, and provisioning functions. Its customer base is horizontal, serving pharmaceutical sponsors conducting trials in oncology, respiratory, cardiovascular, and other therapeutic areas.

The company's core technology is a proprietary end-to-end clinical trial platform developed in-house and tailored to each study, incorporating AI tools for data analysis and biosensors for patient data capture. Banook has expanded its technology and service portfolio through a series of acquisitions: nabios GmbH (Germany, 2021) strengthened cardiac safety and clinical endpoint data solutions; Keosys and B.Research (both acquired June 2024) added central imaging and electronic Clinical Outcomes Assessments (eCOA); and Fluidda was integrated to deepen respiratory imaging capabilities.

Banook generates revenue through professional services engagements structured as project-based contracts for clinical trials, with pricing determined via custom quotes rather than public rate cards. It employs an enterprise field sales motion, engaging pharmaceutical clients directly through quote requests and contact inquiries. The company operates teams across Europe, North America, and Asia-Pacific to provide international coverage, and has secured institutional funding from Idinvest Partners (2020) to support its acquisition-led growth strategy.

Name

Banook

Legal name

Banook

Website

https://banookgroup.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

Banook is a French clinical trial services provider offering cardiac safety, central imaging, respiratory, e-clinical, and endpoint adjudication services to pharmaceutical sponsors globally via a proprietary AI-enabled platform.

Ownership category

akta.pro rank

Product category

Clinical Trial Services

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Forensic & Anti-Counterfeit Testing (Product Integrity) (HLAGADAM)

Keywords

• Clinical trial services
• Cardiac safety monitoring
• Central imaging analysis
• Endpoint adjudication
• ECOA solutions

Headquarters

HQ city

Nancy

HQ country

France

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Clinical Trial Services: Banook generates revenue through providing specialized clinical trial services to pharmaceutical companies. Services include cardiac safety monitoring, central imaging, respiratory endpoints, e-clinical solutions (site and patient solutions, devices), and endpoint adjudication. Revenue is project-based, typically structured as professional services engagements for clinical trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Banook is a French clinical research organization providing specialized clinical trial services to pharmaceutical companies, including cardiac safety monitoring, central imaging, respiratory endpoints, e-Clinical site and patient solutions, and endpoint adjudication. Services are delivered through a proprietary, in-house developed end-to-end platform incorporating AI tools and biosensors, with project-based professional services engagements covering provisioning, project management, data management, and medical/regulatory expertise across global clinical trials.

Product overview

Banook is a global clinical trial technology and services provider offering a unified platform with specialized modules. The core offering includes five integrated service lines: Cardiac Safety, Central Imaging, Respiratory, e-Clinical, and Endpoint Adjudication. These services are supported by a proprietary end-to-end platform incorporating AI tools and biosensors. The company also provides operational support services including Project & Data Management, Regulatory, Site Support, and Provisioning. Recent acquisitions of Keosys and B.Research have expanded capabilities in central imaging and electronic Clinical Outcomes Assessments (eCOA), while the integration of Fluidda has enhanced respiratory imaging services.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiac Safety Cardiovascular monitoring service for clinical trials, encompassing provisioning, project management, data management, and medical expert capabilities for pharmaceutical companies.
• Central Imaging Expert central imaging analysis across therapeutic areas and indications from early to late phase clinical trials, delivering customized services aligned with unique needs at every stage of the development process for pharmaceutical sponsors.
• Respiratory Innovative, patient-centric respiratory endpoint services across all phases of clinical development, providing deeper insight into lung structure, function, and therapeutic impact for pharmaceutical clients.
• e-Clinical Personalized site and patient solutions with devices designed specifically for a successful clinical study experience for pharmaceutical sponsors and trial sites.
• Endpoint Adjudication Comprehensive reviews and expert management of clinical endpoints by a dedicated scientific board, ensuring timely delivery and adherence to regulatory standards for pharmaceutical sponsors.
• Global Platform Proprietary end-to-end clinical trial platform developed in-house and tailored to each study, incorporating AI tools and biosensors for clinical trial data management and analysis.
• Project & Data Management Comprehensive project and data management services for clinical trials, supporting pharmaceutical sponsors with operational execution.
• Regulatory Services Medical and regulatory services for clinical trials, supporting compliance with health authority requirements.
• Site Support Medical site support services for clinical trial operations, providing on-site expertise and coordination for trial sites.
• Provisioning Clinical trial provisioning services for equipment and resources to support trial execution.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ICON plc: ICON is a global full-service CRO with broad capabilities including cardiac safety and imaging; it competes for the same sponsor relationships as Banook but at substantially greater scale.
• Parexel: Parexel is a large global CRO with comprehensive clinical development services including cardiac safety and imaging, competing with Banook for mid-to-large pharmaceutical trial programs.
• IQVIA: IQVIA is the world's largest CRO with end-to-end clinical and commercial services, representing a powerful incumbent against which Banook must position its specialized offerings.
• Labcorp Drug Development (Covance): Labcorp's clinical development arm (formerly Covance) provides central laboratory, cardiac safety, and imaging services overlapping with Banook's portfolio, but at significantly larger scale.

Direct peers

• Medpace: Medpace is a mid-sized full-service CRO with a similar therapeutic-area focus and operational model, competing for the same pharmaceutical sponsors seeking specialized, full-service clinical trial execution.
• Clario: Clario (formed from the merger of ERT and Bioclinica) is the most directly comparable peer, offering cardiac safety, eCOA, and medical imaging services for clinical trials — overlapping almost entirely with Banook's core service lines.
• Premier Research: Premier Research is a mid-sized specialty CRO serving similar biopharma customers across oncology, rare disease, and other therapeutic areas where Banook also operates.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO with comparable therapeutic area depth and a similar focus on complex, specialty clinical trials, making it a direct competitor for Banook's sponsor mandates.
• SGS Life Sciences (Clinical Research): SGS's clinical research services division offers CRO and specialized clinical trial services to pharmaceutical clients, comparable to Banook's mid-size specialty positioning in cardiac safety and imaging.

Emerging players

• ERT (legacy, now part of Clario): ERT was historically the dominant pure-play cardiac safety vendor for clinical trials before merging into Clario; it represents the archetype of a specialist endpoint CRO that Banook is building toward.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/banook-group

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Banook